drugset / Trial / NCT02410382

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

NCT02410382 ↗

Phase 2 Terminated 79 enrolled University of Arizona
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will look at how dexamethasone and placebo influence radiation fatigue, quality of life and number of treatment days missed during radiation therapy or radiation therapy and chemotherapy for cancer.

Timeline

Start
2014-08-27
Primary completion
2018-02-16
Completion
2018-02-16

Outcome

Outcome not reported

Stopped: “IRB suspension, did not resume”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Oral